Santos MM, Obregón SÁ, Piriz AA, Gutiérrez MÁA

Language: Spanish
References: 30
Page:
PDF size: 518.11 Kb.

ABSTRACT

Cardiovascular diseases constitute the leading cause of death in Cuba, 64.9% of which is caused by ischemic heart disease, of which 45.3% is due to acute myocardial infarction. Performing an adequate risk stratification in the patient with a heart attack helps to limit the extent and severity of the irreversible myocardial lesion, which is why it is considered a useful tool to reduce hospital and monthly mortality of patients with heart attack. A search was performed using the ClinicalKey, Medline Complete, EBSCO, Pubmed, Hinari, SciELO search engines on risk stratification in patients with acute myocardial infarction. The objectives and importance of risk stratification, evolution, aspects of interest and the most significant variables are presented. A comparison is made of the risk score that have been used most in the world in recent years, in addition to explaining the characteristics for which the ideal score has not yet been found, exemplifying the main problems presented by the current scales. The importance of creating a risk score in Cuba is analyzed, which serves to homogenize stratification.

REFERENCES

1. Ferreira González I. Epidemiologia de laenfermedad coronaria. Rev Esp Cardiol. 2014; 67(2):139-144. Disponible en: http://dx.doi.org/10.1016/j.recesp.2013.10.003.

2. Reed GW, Rossi JE, Cannon CP. Acutemyocardial infarction. Lancet 2017; 389: 197-210. Disponible en: http://dx.doi.org/10.1016/S0140-6736(16)30677-8

3. Braunwald E, Zipes D, Libby P. Braunwald´sCardiología: El libro de medicina cardiovascular. 9na Ed. Massachussets: W.B.Saunders Company, 2012; 1266-1352.

4. Reed GW, Rossi JE, Cannon CP. AcuteMyocardial Infarction. Lancet. 2017 [citado el 7 de mar de 2018];389(10065): 197-210. Disponible en: DOI:10.1016/S0140-6736(16)30677-8.

5. Marín F, Díaz O, Ruiz JM, García B, Sionis A,López J, et al. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos. Rev Esp Cardiol. [Internet] 2014 [citado el 13 de nov de 2016]; 67(2):120–126. Disponible en: http://dx.doi.org/10.1016/ j.recesp.2013.10.007.

6. García de Castro AM, Narváez Mayorga I,Rodríguez Padial L. Protocolo sobre estratificación y factores de riesgo en pacientes con síndrome coronario agudo. Medicine. 2017; 12 (37): 2248-52

7. De Abreu, M., Mariani, J., Guridi, C., González, G.,Gastaldello, N., Tajer, C., et al. Asociación entre marcadores bioquímicos y disfunción ventricular izquierda en infarto con elevación del segmento ST. (Spanish). Archivos De Cardiología De México. 2014 [citado el 1 de dic de 2016]; 84(4): 243-249. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext &pid=S1405-99402014000400002.

8. Posnenkova OM, Kiselev AR, Popova YV, GridnevVI, Prokhorov MD, Dovgalevsky PY, et al. Impact of patient-related and treatment-related factors on in-hospital mortality of patients with ST- elevation myocardial infarction: Data of Russian Acute Coronary Syndrome Registry. COR ET VASA. 2014;56 (3): e2127-e227. Disponible en: http://dx.doi.org/10.1016/j.crvasa.2014.03.004

9. Borja I, James S, Agewall S, Antunez M,Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST – segment elevation. European Heart Journal 2017; 39(2): 119-77.Disponible en: http://doi: 10.1093/eurheart/ehx393

10. Abu-Assi E, García Acuña JM, Peña Gil C,González Juanatey JR. Validación en una cohorte contemporánea de pacientes con síndrome coronario agudo del store GRACE predictor de mortalidad a los 6 meses de seguimiento. Rev Esp Cardiol.2010; 63(6): 640-8.

11. De Winter R. Estrategias de tratamiento yestratificación del riesgo en los síndromes coronarios agudos: ¿cómo identificar a los pacientes que se pueden beneficiar de un abordaje invasivo temprano? Rev Esp Cardiol.2010; 63(8): 888-9.

12. Fox KA, Langrish JP. Estratificación del riesgo enlos síndromes coronarios agudos. Rev Esp Cardiol. 2010;63(6):629-32

13. Shaw LJ, Peterson ED, Kesler K, Hasselblad V,Califf RM. A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol. 1996;78:1327-37.

14. Fox KA, Anderson FA, Dabbous OH, Steg PG,López – Sendón J, Van de Werf, et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristic? The Global Registry of Acute Coronary Events (GRACE). Heart 2007; 93: 177-82.

15. Araújo Goncalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. European Heart Journal 2005; 26: 865-72.

16. Andrew TY, Raymond T, Huynh T, Casanova A,Raimondo E, Fitchett DH, et al. Understanding Physicians´ Risk Stratification of Acute Coronary Syndromes. Arch Intern Med 2009; 169(4): 372-78.

17. Cooney MT, Dudina AL, Graham IM. Value andlimitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol. 2009; 54:1209-27.

18. Fox KA; Anderson FA; Dabbous OH; Steg PG;Lopez-Sendon J; Van de Werf F; Budaj A; Gurfinkel EP; Goodman SG; Brieger D+ GRACE investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE).Heart. 2007 February; 93(2). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1861403/?tool=pubmed

19. Elbarouni B, Goodman SG, Yan RT, Welsh RC,Kornder JM, Deyoung JP, et al. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada. Am Heart J.2009;158:392-9.

20. Antman EM, Cohen M, Bernink PJ, et al. The TIMIrisk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.

21. Domínguez Rodríguez A, Abreu González P.Estratificación pronóstico dinámica en el infarto agudo de miocardio con elevación del segmento ST. Rev Esp Cardiol. 2014; 67(7): 587-588. Disponible en: http://dx.doi.org/10.1016/j.recesp.2014.02.016.

22. Saar A, Marandi T, Ainla T, Fischer K, Blondal M,Eha J. The risk- treatment paradox in non-ST-elevation myocardial infarction patients according to their estimated GRACE risk. International Journal of Cardiology. 2018; 272: 26-32. Disponible en: http://doi.org/10.1016/j.ijcard.2018.08.015.

23. Zapata GO. Predicción temprana del riesgo en elinfarto agudo de miocardio: una difícil tarea de todos los días. Rev Fed Arg Cardiol 2011; 40 (1): 1-2

24. Singh M, Reeder GS, Jacobsen SJ, Weston S,Killian J, Roger V. Scores post-myocardial infarction risk stratification in the community. Circulation. 2002; 106: 2309-14.

25. Ministerio de Salud Pública. Anuario Estadístico2018. La Habana: MINSAP; 2019. Disponible en: www.slsd.cu/sitios/dne.

26. Millard RW, Tranter M. Rev Esp Cardiol. 2014;67(4):312-20.

27. Cordero Sandoval Q, Ramirez Gomez JI, Moreno-Martinez FL, Gonzalez Alfonso O. Valor predictivo de algunos modelos de estratificación de riesgo en pacientes con infarto agudo de miocardio con elevación del ST. CorSalud 2013 Ene-Mar;5(1):57-71

28. Rizo GO, Ramírez JI, Pérez D, Novo L, Acosta F,Cordero Q, et al. Valor predictivo de muerte y complicaciones intrahospitalarias de los modelos de estratificación de riesgo en pacientes con infarto miocárdico agudo. Rev Fed Arg Cardiol. 2011;40(1): 57-64.

29. Santos Medina M, Valera Sales A, OjedaRiquenes Y, Pardo Pérez L. Validacion del score GRACE como predictor de riesgo tras un infarto agudo de miocardio. Rev Cubana Cardiol Cir Cardiovasc. 2015; 21(2)

30. Nallamothu BK, Bates ER, Wang Y. Drivind timesand distances to hospitals with percutaneous coronary intervention in the United States: implicatios for prehospital triage of patients with ST-elevation myocardial infarction. Circulation 2006; 113(9):1189-11951.